↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.5MSold on the market
1Companies
Sep 3, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202616:30 | Sep 1, 2026 | DNTHDianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | S · Sell10b5-1 | $106.41 | −23,124 | 4,000 | -85% | −$2.5M | ||
| Sep 3, 202616:30 | Sep 1, 2026 | DNTHDianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | M · Exercise10b5-1 | $20.63 | +23,124 | 27,124 | +578% | $477K |